Abstract:Objective:To observe the effects of transurethral split of the prostate (TUSP) on the urodynamics, the sexual function and the quality of life of benign prostatic hyperplasia.Methods:Eighty patients with benign prostatic hyperplasia admitted to the Deqing People′s Hospital of Zhejiang Province from January 2017 to June 2019 were enrolled into the research objects prospectively. According to the random digits table method, they were divided into group A and group B, with 40 cases in each group. The group A was treated with TUSP, while the group B was treated with bipolar transurethral plasma kinetic prostatectomy (TUPKP). The operation time, intraoperative blood loss, bladder irrigation time, urinary catheter indwelling time, hospitalization time of the two groups were compared and surgical effects were evaluated. The changes of hemoglobin (Hb), serum sodium (Na), post-void residual volume (PVR), maximum urinary flow rate (Q max), international prostate symptom score (IPSS) and international index of erectile function score (IIEF-5), the quality of life index (QOL) of 2 groups before and after the operation were measured. Surgical complications were recorded. Results:The operation time, bladder irrigation time, urinary catheter indwelling time and hospital stay in group A were all shorter than that in group B: (15.63 ± 4.17) min vs. (58.79 ± 10.45) min, (6.26 ± 1.17) h vs. (45.51 ± 10.03) h, (3.07 ± 0.68) d vs. (5.67 ± 1.51) d, (3.63 ± 0.43) d vs. (6.08 ± 1.72) d, (18.32 ± 2.79) ml vs. (65.26 ± 20.64) ml, and there were statistical differences ( P<0.05); there were no statistical difference between 2 groups in surgical curative effect grade and Na 1 d after operation ( P>0.05); 1 day after operation, Hb in group A was higher than that in group B: (115.63 ± 9.78) g/L vs. (109.65 ± 8.36) g/L, and there was statistical difference ( P<0.05); PVR, Q max, IPSS, IIEF-5 and QOL 3 and 6 months after surgery were improved in 2 groups ( P<0.05), but the difference between 2 groups was not statistically significant ( P>0.05); the total complication rate in group A was lower than that in group B: 10.00% (4/40) vs. 27.50% (11/40), and there was statistical difference ( P<0.05). Conclusions:TUSP and TUPKP are equally effective in the treatment of benign prostatic hyperplasia, both of which can improve the symptoms of prostatic hyperplasia, improve the quality of life and improve sexual function. But TUSP has less intraoperative bleeding, shorter operation time, faster postoperative recovery, fewer complications, and higher safety.

The relationship between human papilloma virus and benign prostatic hyperplasia complicated with bacterial prostatitis and the optimal treatment method

Prostatic Calculi Influence the Antimicrobial Efficacy in Men with Chronic Bacterial Prostatitis

The value of transurethral cylindrical dilatation of the prostate in the treatment of patients with benign prostatic hyperplasia

A retrospection of 1345 cases of inpatients with Benign prostatic hyperplasia in the past 10 years

Clinical analysis of BPH and BPH with chronic prostatitis

Clinical observation of Qianlie Shutong Capsules combined with finasteride in treatment of benign prostatic hyperplasia

Impacts of Histological Prostatitis on Sexual Function and Lower Urinary Tract Symptoms in Patients with Benign Prostatic Hyperplasia

Diagnosis of Chronic Prostatitis by Noninvasive Methods in Elderly Patients with Benign Prostatic Hyperplasia in China

A preliminary study on the efficacy and mechanism of Chinese traditional medicine Zeguilongshuang capsule for the treatment of benign prostatic hyperplasia

Comparative efficacy of commercial oral poly-herbal traditional Chinese medicine formulations combined with western medicine in benign prostatic hyperplasia management: a systematic review and network meta-analysis

Correlation between Prostatitis, Benign Prostatic Hyperplasia and Prostate Cancer: A systematic review and Meta-analysis

Clinical study the relationship between symptomatic parameters of benign prostate hyperplasia and sexual function

Detection Rate of Benign Prostatic Hyperplasia with Histological Prostatitis: Comparison Between Two Different Diagnostic Standards

[A Clinical Study of Prostat Combined with an Antibiotic for Chronic Nonbacterial Prostatitis].

Understanding Chinese Patients Attitude Towards BPH and BPH Treatment: Result of Prostate Health Educational Programmer Study

Symptomatic Comparison in Efficacy on Patients with Benign Prostatic Hyperplasia Treated with Two Therapeutic Approaches

Exploring the Efficacy of the Traditional Chinese Medicine Compound Formulas Qianlong Shutong Formula in the Treatment of Benign Prostatic Hyperplasia

Effect of QianlieShutong capsule combined with tamsulosin on serum testosterone and estrogen in patients with benign prostatic hyperplasia and its efficacy

[Compound Ciprofloxacin Suppository Combined with Ningbitai and Yunnan Baiyao for Histological Prostatitis with PSA Elevation].

Effects of Qianlie’an Suppository in Patients with Chronic Prostatitis Syndrome: A Randomized Open-Labelled Prospective and Controlled Trial

Clinical Observation of Combined Cavity Interventional Therapy and Traditional Chinese Medicineon Prostatitis Type Ⅲ